Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - The NOWAC postgenome study

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Waaseth, Marit ^a   Olsen, Karina S ^a   Rylander, Charlotta ^a,b   Lund, Eiliv ^a   Dumeaux, Vanessa ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b NORWEGIAN INSTITUTE FOR AIR RESEARCH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; FOLLITROPIN; GESTAGEN; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TIBOLONE; RNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; IMMUNE RESPONSE; MICROARRAY ANALYSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOM SAMPLE; BLOOD; DNA MICROARRAY; ESTROGEN THERAPY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; NORWAY;

CLUSTER ANALYSIS; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENE EXPRESSION PROFILING; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; NORWAY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POSTMENOPAUSE; RNA;

EID: 79953171205     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-29     Document Type: Article

References (43)

1. (The Endogenous Hormones and Breast Cancer Collaborative Group) Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies. TJ Key P Appleby I Barnes G Reeves, J Natl Cancer Inst 2002 94 606 616 11959894 (Pubitemid 34498648)
2. Endogenous Estrogen, Androgen, and Progesterone Concentrations and Breast Cancer Risk Among Postmenopausal Women. SA Missmer AH Eliassen RL Barbieri SE Hankinson, J Natl Cancer Inst 2004 96 1856 1865 10.1093/jnci/djh336 15601642 (Pubitemid 40081323)
3. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. R Kaaks S Rinaldi TJ Key F Berrino PHM Peeters C Biessy L Dossus A Lukanova S Bingham KT Khaw, et al. Endocr Relat Cancer 2005 12 1071 1082 10.1677/erc.1.01038 16322344 (Pubitemid 41815798)
4. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative, JAMA 2002 288 321 333 10.1001/jama.288.3.321 12117397
5. Breast cancer and hormone-replacement therapy in the Million Women Study. Million Women Study Collaborators, The Lancet 2003 362 419 427 10.1016/S0140-6736(03)14065-2 (Pubitemid 36999703)
6. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study. K Bakken E Alsaker AE Eggen E Lund, Int J Cancer 2004 112 130 134 10.1002/ijc.20389 15305384 (Pubitemid 39249500)
7. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer Postgenome Cohort - a cross-sectional analysis. M Waaseth K Bakken V Dumeaux K Olsen C Rylander Y Figenschau E Lund, BMC Women's Health 2008 8 1
8. Circulating Hormone Levels in Menopausal Women Receiving Different Hormone Replacement Therapy Regimens. C Castelo-Branco MJM de Osaba A Fortuny X Iglesias J Gonzalez-Merlo, J Reprod Med 1995 40 556 560 7473451
9. Effect of Postmenopausal Estrogen Replacement on Circulating Androgens. PR Casson KE Elkind-Hirsch JE Buster PJ Hornsby SA Carson MC Snabes, Obstetrics & Gynecology 1997 90 995 998 (Pubitemid 27510144)
10. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels - an association with mammographic density. M Hofling K Carlström G Svane E Azavedo H Kloosterboer BV Schoultz, Gynecol Endocrinol 2005 20 110 115 10.1080/09513590400021151 15823831 (Pubitemid 40604027)
11. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. M Dören A Rübig HJT Coelingh Bennink W Holzgreve, Fertil Steril 2001 75 554 559 11239541 (Pubitemid 32175672)
12. The peripheral blood transcriptome dynamically reflects system wide biology: A potential diagnostic tool. CC Liew J Ma HC Tang R Zheng AA Dempsey, Journal of Laboratory and Clinical Medicine 2006 147 126 132 10.1016/j.lab.2005.10.005 16503242 (Pubitemid 43288168)
13. The peripheral-blood transcriptome: new insights into disease and risk assessment. S Mohr CC Liew, Trends in Molecular Medicine 2007 13 422 432 10.1016/j.molmed.2007.08.003 17919976 (Pubitemid 47562311)
14. Cancer biomarkers: knowing the present and predicting the future. SK Chatterjee BR Zetter, Future Oncology 2005 1 37 50 10.1517/14796694.1.1.37 16555974
15. Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. V Dumeaux J Johansen AL Borresen-Dale E Lund, Mol Cancer Ther 2006 5 868 876 10.1158/1535-7163.MCT-05-0329 16648556 (Pubitemid 43724585)
16. Comparison of globin RNA processing methods for genome-wide transcriptome analysis from whole blood. V Dumeaux E Lund AL Børresen-Dale, Biomarkers Med 2008 2 11 21 10.2217/17520363.2.1.11 (Pubitemid 351445076)
17. Effect of Menopause on Gene Expression Profiles of Circulating Monocytes: A Pilot in vivo Microarray Study. V Dvornyk Y Liu Y Lu H Shen JM Lappe RR Recker H Deng S Lei, Journal of Genetics and Genomics 2007 34 974 983 10.1016/S1673-8527(07)60110-6 18037134 (Pubitemid 350123213)
18. In vivo genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. P Xiao Y Chen H Jiang YZ Liu F Pan TL Yang ZH Tang JA Larsen JM Lappe RR Recker Hw Deng, Journal of Bone and Mineral Research 2008 23 644 654 10.1359/jbmr.080105 18433299 (Pubitemid 351575018)
19. Muscular Transcriptome in Postmenopausal Women With or Without Hormone Replacement. E Pollanen P Ha Ronkainen H Suominen T Takala S Koskinen J Puolakka S Sipila V Kovanen, Rejuvenation Research 2007 10 485 500E 10.1089/rej.2007. 0536 17985945
20. Impact of Estrogen Deprivation on Gene Expression Profiles of Normal Postmenopausal Breast Tissue In vivo. A Kendall H Anderson AK Dunbier A Mackay T Dexter A Urruticoechea C Harper-Wynne M Dowsett, Cancer Epidemiol Biomarkers Prev 2008 17 855 863 10.1158/1055-9965.EPI-07-2718 18398027 (Pubitemid 351536416)
21. Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype. J Frasor JM Danes B Komm KCN Chang CR Lyttle BS Katzenellenbogen, Endocrinology 2003 144 4562 4574 10.1210/en.2003-0567 12959972 (Pubitemid 37204856)
22. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Q Ji PI Liu PK Chen C Aoyama, International Journal of Cancer 2004 112 803 814 10.1002/ijc.20478 (Pubitemid 39435265)
23. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. V Dumeaux AL Borresen-Dale JO Frantzen M Kumle V Kristensen E Lund, Breast Cancer Research 2008 10 13 10.1186/bcr1859 18271962
24. Cohort Profile: The Norwegian Women and Cancer Study - NOWAC - Kvinner og kreft. E Lund V Dumeaux T Braaten A Hjartaker D Engeset G Skeie M Kumle, Int J Epidemiol 2008 37 36 41 10.1093/ije/dym137 17644530 (Pubitemid 351228607)
25. Deciphering Normal Blood Gene Expression Variation - The NOWAC Postgenome Study. V Dumeaux KS Olsen G Nuel RH Paulssen AL Børresen-Dale E Lund, PLoS Genet 2010 6 1000873 10.1371/journal.pgen.1000873 20300640
26. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. GK Smyth, Stat Appl Genet Mol Biol 2004 3 Article 3 16646809
27. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Y Benjamini Y Hochberg, J R Stat Soc Series B Stat Methodol 1995 57 289 300
28. KEGG: Kyoto Encyclopedia of Genes and Genomes. M Kanehisa S Goto, Nucl Acids Res 2000 28 27 30 10.1093/nar/28.1.27 10592173 (Pubitemid 30047706)
29. AmiGO: online access to ontology and annotation data. S Carbon A Ireland CJ Mungall S Shu B Marshall S Lewis the AmiGO Hub, the Web Presence Working Group, Bioinformatics 2009 25 288 289 10.1093/bioinformatics/btn615 19033274
30. A global test for groups of genes: testing association with a clinical outcome. JJ Goeman SA van de Geer F de Kort HC van Houwelingen, Bioinformatics 2004 20 93 99 10.1093/bioinformatics/btg382 14693814 (Pubitemid 38088346)
31. GeneCardsTM 2002: towards a complete, object-oriented, human gene compendium. M Safran I Solomon O Shmueli M Lapidot S Shen-Orr A Adato U Ben-Dor N Esterman N Rosen I Peter, et al. Bioinformatics 2002 18 1542 1543 10.1093/bioinformatics/18.11.1542 12424129 (Pubitemid 35414549)
32. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. DW Huang BT Sherman RA Lempicki, Nat Protocols 2008 4 44 57 10.1038/nprot.2008.211
33. Exploring the human genome with functional maps. C Huttenhower EM Haley MA Hibbs V Dumeaux DR Barrett HA Coller OG Troyanskaya, Genome Res 2009 19 1093 1106 10.1101/gr.082214.108 19246570
34. TSC22D1 and PSAP predict clinical outcome of tamoxifen treatment in patients with recurrent breast cancer. D Meijer M Jansen M Look K Ruigrok-Ritstier I van Staveren A Sieuwerts T van Agthoven J Foekens L Dorssers E Berns, Breast Cancer Research and Treatment 2009 113 253 260 10.1007/s10549-008-9934-3 18299979
35. Sex Hormone-binding Globulin (SHBG) and Estradiol Cross-talk in Breast Cancer Cells. N Fortunati MG Catalano, Horm Metab Res 2006 38 236 240 10.1055/s-2006-925337 16700004 (Pubitemid 43845215)
36. Sex hormones and the immune response in humans. A Bouman MJ Heineman MM Faas, Hum Reprod Update 2005 11 411 423 10.1093/humupd/dmi008 15817524 (Pubitemid 40895468)
37. Non-genomic actions of sex steroid hormones. T Simoncini A Genazzani, Eur J Endocrinol 2003 148 281 292 10.1530/eje.0.1480281 12611608 (Pubitemid 36410713)
38. Effects of exercise on gene expression in human peripheral blood mononuclear cells. PH Connolly VJ Caiozzo F Zaldivar D Nemet J Larson Sp Hung JD Heck GW Hatfield DM Cooper, J Appl Physiol 2004 97 1461 1469 10.1152/japplphysiol.00316.2004 15194674 (Pubitemid 39299366)
39. Selective Estrogen Receptor Modulators: Discrimination of Agonistic versus Antagonistic Activities by Gene Expression Profiling in Breast Cancer Cells. J Frasor F Stossi JM Danes B Komm CR Lyttle BS Katzenellenbogen, Cancer Res 2004 64 1522 1533 10.1158/0008-5472.CAN-03-3326 14973112 (Pubitemid 38235626)
40. Tibolone revisited: still a good treatment option for healthy, early postmenopausal women. P Kenemans, Gynecological Endocrinology 2010 26 237 239 10.3109/09513590903507339 20017707
41. Biological microarray interpretation: The rules of engagement. R Breitling, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2006 1759 319 327 10.1016/j.bbaexp.2006.06.003 (Pubitemid 44332592)
42. Application of genome-wide expression analysis to human health and disease. JP Cobb MN Mindrinos C Miller-Graziano SE Calvano HV Baker W Xiao K Laudanski BH Brownstein CM Elson DL Hayden, et al. Proc Natl Acad Sci USA 2005 102 4801 4806 10.1073/pnas.0409768102 15781863 (Pubitemid 40471534)
43. High-protein and high-carbohydrate breakfasts differentially change the transcriptome of human blood cells. MJ van Erk WA Blom B van Ommen HF Hendriks, Am J Clin Nutr 2006 84 1233 1241 17093179 (Pubitemid 44730397)